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Effects of Promoters on N Butyl N (4
hydroxybutyl)nitrosamine.Induced Urinary
Bladder Carcinogenesis in the Rat
by Nobuyuki Ito,* Shoji Fukushima,* Tomoyuki Shirai,*
and Keisuke Nakanishi*
It has been shown that the occurrence of the preneoplastic lesion, papillary or nodular hyperpla-
sia (PN hyperplasia) in rat urinary bladder induced by carcinogens is correlated with that of cancer.
Therefore, the promoting effects of chemicals in two-stage bladder carcinogenesis were judged by
measuring their ability to induce PN hyperplasia in rats. Male rats were givenN-butyl-N44-hydroxy-
butyl)nitrosamine (BBN) for 4 weeks and then one of 16 test chemicals for 32 to 34 weeks. Saccharin,
ascorbate, DL-tryptophan, allopurinol, and diphenyl promoted development of PN hyperplasia. The
dose-response of the promoters were examined in both sexes of rats by administration of saccharin
at doses of 0.04, 0.2, 1.0 and 5.0% for 32 weeks after BBN treatment. The occurrence of PN hyper-
plasia was significantly increased in the group given 5% saccharin. Dose-response curves showed
enhanced hyperplastic responses in both sexes given 0.2 to 5% saccharin.
The organ specificities of promoters were studied in rats initiated with BBN or 2-acetylamino-
fluorene (2-AAF) followed by phenobarbital or saccharin for 32 weeks. Phenobarbital greatly en-
hanced hepatocarcinogenesis. Saccharin significantly enhanced the occurrence of both BBN-induced
and 2-AAF-induced PN hyperplasia. However, there was no effect of phenobarbital on the urinary
bladder or of saccharin on the liver.
The rats showed a strain difference in susceptibility of the urinary bladder to saccharin; ACI rats
were most susceptible and Sprague Dawley rats were most resistant to saccharin.
The membrane potential of superficial epithelial cells in the urinary bladder of rats treated with
saccharin was measured with an intracellular microelectrode and found to be higher than that of
controls.
Introduction
The two-stage process of chemical carcinogenesis,
initiation and promotion, was initially proposed
from studies on mouse skin and has subsequently
been demonstrated in other organs, such as the
liver, colon and urinary bladder (1-3). The two-stage
process of urinary bladder carcinogenesis has been
demonstrated in rats using single intravesical instil-
lation of methylnitrosourea (4) or initiation by N-[4-
(5-nitro-2-furyl)2-thiazolyl]formamide (FANFT) (5),
followed by treatment with saccharin. In the pres-
ent studies we examined the promoting effects of
various chemicals on urinary bladder carcinogenesis
in rats initiated by N-butyl-N-4-hydroxybutyl)nitros-
amine (BBN) and evaluated the in vivo biological
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characteristics of tumor promoters in urinary blad-
der carcinogenesis using saccharin as a typical pro-
moter. Effects were mainly judged by measuring
the formation of the preneoplastic lesion and papil-
lary and nodular hyperplasia of the urinary bladder.
The Preneoplastic Lesion and
Histological Observation
BBN is a potent carcinogen in the urinary blad-
der of animals. There have been many reports on
the carcinogenicity of BBN in rat urinary bladder
(6-8). Histological lesions in the urinary bladder of
rats induced by BBN were classified into four types,
simple hyperplasia, PN hyperplasia, papilloma and
cancer (9). As shown in Figure 1, PN hyperplasia of
the urinary bladder in rats treated with 0.05% BBN
developed before the induction of papilloma or can-
cer (6). The incidence of PN hyperplasia in the uri-nary bladder of rats treated with various doses of
BBN for different periods is shown graphically in
Figure 2 (7). A high dose of BBN induced a high inci-
dence of PN hyperplasia in a short period. Dose-re-
sponse relationships were observed for the induc-
tion of PN hyperplasia, the dose of BBN, and the
period of BBN treatment. Moreover, a good correla-
tion was found between the inductions of PN hyper-
plasia and cancer with different doses of BBN.
Thus, it is clear that PN hyperplasia is a preneoplas-
tic lesion of rat urinary bladder, and can be used as
a marker in studies on the 2-stage process of uri-
nary bladder carcinogenesis.
For histological examination of the urinary blad-
der, rats were killed with ether, 10% phosphate-
buffered formalin (pH 7.4) was injected into the uri-
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nary bladder through the urethra, and the urinary
bladder was then divided in half sagitally. Each half
was cut into four to six strips, which were embed-
dee in paraffin. Tissue sections were stained with
hematoxylin and eosin. In quantitative analyses, the
numbers of lesions were counted under a light
microscope, the total length of the basement mem-
brane was measured with a color video image pro-
cessor (VIP-21 or 21C; Olympus- Ikegami Tsushin
Co., Tokyo, Japan), and the results were expressed
as the number of lesions per 10 cm of basement
membrane.
Promoting Effects of Various
Chemicals in Rat Urinary Bladder
Carcinogenesis Initiated by BBN
______ Saccharin and tryptophan are known to act as
promoters after initiation of the urinary bladder
with carcinogens (4,5,10). Various chemicals are
N / / present in the environment and a high proportion of PN hyperplasia / * human cancers is attributable to environmental fac-
Papilloma tors. Thus since some of the environmental chemi-
cals to which humans are exposed may promote uri-
// /Cancer nary bladder carcinogenesis, special consideration
should be paid to evaluation of their promoting ac-
°0 / /'tivities. Accordingly, the following experiment was
carried out. Carcinogenesis of the urinary bladder
4 * 12 16 20 was initiated in male 6-week-old F344 or Wistar rats
Weeks by adding 0.01°/ BBN to their drinking water for 4
lence of urinary bladder lesions in rats given weeks, and then the animals were given a test
,l-N-(4-hydroxybutyl)nitrosamine. chemical to examine its promoting activity. The
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FIGURE 2. Incidence of PN hyperplasia in the urinary bladder of rats givenN-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
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chemicals tested, their dose levels and the observa-
tion periods used are shown in Figure 3.
The incidence and number of PN hyperplasia per
10 cm of basement membrane are shown in Table 1.
Administration of 5% saccharin, but not 0.5% sac-
charin, significantly increased the incidence and
number of PN hyperplasia. This finding could be re-
lated to the induction of cancers in rat urinary blad-
der by high levels of saccharin. Sodium ascorbate,
DL-tryptophan, allopurinol and diphenyl also in-
creased the numbers of PN hyperplasia signifi-
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0.01% BBN in drinking water
Test chemical in diet or in drinking water
1. 5.0% soccharin 9. 5.0% sodisxn hippurate
2. 0.5% soccharin 10. 5.0%aspartcne
3. 5.0% sodium ascorbate 11. 2.5% sodium cyclamate
4. 5.0% calcium carbonate 12. 0.5% diphenyl
5. 5.0% DL-tryptophan 13. 2.0%o-phsnylphenal
6. 0.02% allopurinol 14. 0.0025% nicatin
7. 0.35% acetozolamide 15. 2.5% phenacetin
8. 5.0% quercetin 16. 0.1% caffeine
1Bosal diet
FIGURE 3. Experimental protocol for the evaluation of
promoting activity of various chemicals in two-stage
bladder carcinogenesis of rats initiated by N-butyl-N-(4-
hydroxybutyl)nitrosamine (BBN).
cantly, but other test chemicals, such as acetazola-
mide, quercetin, cyclamate, o-phenylphenol, and caf-
feine did not. Results on saccharin and tryptophan
are consistent with previous findings (5) and sug-
gest that sodium ascorbate, allopurinol and diphenyl
have promoting activities in urinary bladder carci-
nogenesis in rats. No correlation was found between
the number of crystals in the urine sediment and
promotion of preneoplastic lesion, but further stud-
ies are required on this problem.
c38 Aks Dose-Response Relationship of
I Saccharin as a Promoter of Urinary
I Bladder Carcinogenesis
In general, chemical carcinogens show dose-
response relation for both tumor induction and the
length of the induction period (8,11). Dose-response
studies have been undertaken with the use of sac-
charin as a promoter for preneoplastic lesions in the
urinary bladder (12). F344 rats of both sexes were
initiated by treatment with 0.01% BBN in their
drinking water for 4 weeks and then given diets
containing saccharin at concentrations of 5, 1, 0.2,
0.04 and 0% for 32 weeks. The animals were killed
at the end of week 36. The incidences and average
numbers of PN hyperplasia per 10 cm of basement
Table 1. Promotion effects of various chemicals on the induction of PN hyperplasia in rat urinary bladder initiated by
N-butyl-N(4-hydroxybutyl)nitrosamine (BBN).a
Observation PN hyperplasiac
Administration Rat period, No. of No./10 cm of
Test Chemical routeb strain weeks rats Incidence, % basement membrane
Saccharin (5.0%) D F344 38 30 25 (83.3)* 2.2 + 2.7**
Saccharin (0.5%) D F344 38 30 14 (46.7) 1.0 + 1.5
Sodium ascorbate D F344 38 29 19 (65.5) 2.0 ± 2.1
Calcium carbonate D F344 38 30 14 (46.7) 0.7 ± 0.8
DL-Tryptophan D F344 38 30 16 (53.3) 1.5 ± 1.9
Allopurinol D F344 38 28 16 (57.1) 1.9 ± 2.3**
Acetazolamide D F344 38 27 12 (44.1) 0.9 ± 1.5
Quercetin D F344 38 29 9 (31.0) 0.4 ± 0.6
Sodium hippurate D F344 38 30 11 (36.7) 0.6 ± 0.8
Aspartame D F344 36 28 8 (28.6) 0.5 ± 0.6
Sodium cyclamate D F344 36 30 17 (56.7) 0.7 ± 0.7
Diphenyl D F344 36 25 8 (32.0) 1.4 ± 0.8
o-Phenylphenate D F344 36 30 8 (26.7) 1.1 ± 0.1
Nicotine W F344 36 30 10 (33.3) 0.4 ± 0.5
Phenacetin D Wistar 36 28 16 (57.1) 2.1 ± 3.4
Caffeine W Wistar 36 28 12 (43.0) 0.6 ± 0.8
None - F344 38 60 27 (45.0) 0.6 ± 0.8
None - F344 36 28 11 (39.3) 0.7 ± 0.8
None - Wistar 36 23 6 (26.1) 0.5 ± 1.3
aThe rats were initiated with 0.01% BBN in their drinking water for 4 weeks.
bD = in diet; W = in drinking water.
CValues are means ± SD.
***p < 0.05 compared with no test chemical.
**p < 0.01 compared with no test chemical.
*p < 0.001 compared with no test chemical.
63membrane in males and females treated with sac-
charin after BBN are shown in Tables 2 and 3, re-
spectively. The incidences in males with a dose of
5% saccharin and in females with doses of 5% and
1% were significantly higher than those with BBN
alone. Plots of the incidence of PN hyperplasia
against the dose of saccharin gave parabolic curves
in both sexes (Fig. 4); those dose-response curves
showed enhanced hyperplastic responses in both
sexes given 0.2 to 5% saccharin. Administration of
various doses of saccharin without BBN did not
cause any changes in the urinary bladder of rats of
either sex. Although no increase in the induction of
papilloma or cancer by saccharin was noted in
either sex after BBN administration, the results
suggest that if the experimental period had been
longer, a dose-response relationship for the induc-
tion of papilloma and cancer might have been ob-
served. A similar dose-response relation for the ef-
fect of a promoter has been reported (13) for liver
carcinogenesis initiated by 2-acetylaminofluorene (2-
AAF).
Promoting Effects of Saccharin
with Two Different Initiating Doses
of BBN
It is generally accepted that initiation of chemical
carcinogenesis is brought about by chemicals that
are mutagenic in a short-term in vitro assay. Dose-
related mutagenic effects have been reported for
many chemical carcinogens, and in vivo dose-
response relations of initiation activities have been
studied in two-stage carcinogenesis in the skin and
liver (14,15).
Table 2. Lesions of the urinary bladder in male rats initiated byN-butyl-N(4-hydroxybutyl)nitrosamine (BBN)
followed by different doses of saccharin.
Treatmenta PN hyperplasiab Papillomab
Dose of No. of No./10 cm of No./10 cm of
BBN saccharin 0/ rats Incidence, % basement membrane Incidence, % basement membrane
+ 5.0 29 24 (82.80 2.6 ± 2.2*** 6 (20.7) 0.2 ± 0.4
+ 1.0 30 19 (63.3) 1.2± 1.7 10 (33.3) 0.3±0.4
+ 0.2 30 14 (46.7) 0.9 ± 1.2 8 (26.7) 0.3 ± 0.5
+ 0.04 30 12 (40.0) 0.6 ± 0.8 11 (36.7) 0.3 ± 0.4
+ 0 28 11 (39.3) 0.7± 1.0 8 (28.6) 0.4± 0.7
- 5.0 28 0 - 0 0 - 0
- 1.0 28 0 - 0 0 - 0
- 0.2 30 0 - 0 0 - 0
- 0.04 29 0 - 0 0 - 0
- 0 29 0 - 0 0 - 0
aThe rats were initiated with 0.01% of the drinking water for 4 weeks.
bValues are means ± SD.
***p < 0.05 compared with BBN alone.
*p < 0.001 compared with BBN alone.
Table 3. Lesions of the urinary bladder in female rats initiated byN-butyl-N(4-hydroxybutyl)nitrosamine (BBN)
followed by different doses of saccharin.
Treatmenta PN hyperplasiab Papillomab
Dose of No. of No./10 cm of No./10 cm of
BBN saccharin % rats Incidence, % basement membrane Incidence, % basement membrane
+ 5.0 31 23 (74.2w 2.9 ± 3.7** 1 (3.2) 0.1 + 0.4
+ 1.0 30 17 (56.7)*** 1.4 ± 1.8 2 (6.7) 0.1 ± 0.3
+ 0.2 31 14 (45.2) 1.4 ± 2.0 1 (3.2) 0.0 ± 0.2
+ 0.04 31 11 (35.5) 1.0 ± 1.9 1 (3.2) 0.0 ± 0.2
+ 0 29 9 (31.0) 0.7± 1.2 8 (3.4) 0.0±0.2
- 5.0 32 0 - 0 0 - 0
- 1.0 30 0 - 0 0 - 0
- 0.2 31 0 - 0 0 - 0
- 0.04 31 0 - 0 0 - 0
- 0 30 0 - 0 0 - 0
aThe rats were initiated with 0.01% BBN in their drinking water for 4 weeks.
bValues are means ± SD.
***p < 0.05 compared with BBN alone.
**p < 0.01 compared with BBN alone.
*p < 0.001 compared with BBN alone.
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We examined the promoting effect of saccharin
after initiation with two different doses of BBN.
Male 6-week-old F344 rats were divided into five
groups. In the initiation stage, the rats were given
drinking water containing solutions of 0.05%, 0.01%
or 0% BBN for 4 weeks. Then in the promotion
stage, they were given diet containing 5% saccha-
rin or basal diet for 32 weeks.
The incidences and numbers of PN hyperplasia
per 10 cm of basement membrane in the urinary
bladder are shown in Table 4. The incidence and
number of PN hyperplasia and cancer in the groups
that received 0.01 or 0.05% BBN followed by sac-
charin was significantly higher than in the respec-
tive BBN groups without saccharin. In the groups
treated with 0.01% BBN, administration of saccha-
rin also increased the occurrence of PN hyperplasia
significantly. The inductions of PN hyperplasia and
cancer in the group treated with the high dose of
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BBN followed by saccharin were greater than those
in the group treated with the low dose of BBN fol-
lowed by saccharin. Thus, in the present study, the
two different doses of BBN showed a dose-response
relationship for initiation of urinary bladder carcino-
genesis that was promoted by saccharin. These re-
sults are consistent with those on the promoting ef-
fect of phenacetin in two-stage carcinogenesis or rat
urinary bladder initiated by two different doses of
BBN (9).
Organ-Specific Effects of
Promoters
For study of the organ specific effects of two dif-
ferent tumor promoters, rats were divided into
eight groups. In the initiation stage, the rats were
given 0.02% 2-AAF in the diet for 4 weeks, or
0.01% BBN in the drinking water for 4 weeks, or
neither 2-AAF nor BBN for 4 weeks. Then, in the
promotion stage, they were given 0.05% phenobar-
bital in the diet, or 5.0% saccharin in the diet, or
basal diet for 32 weeks. The experimental protocol
is shown in Figure 5. Phenobarbital greatly en-
0 4
50
30 F
Control 400 2,000 10,000 50,000 ppm
(0.04%;) (0.2%) (1.0%) (5.0%)
Dose of socchariin in diet after BBN
FIGURE 4. Dose-response curve for incidence of papillary or
nodular hyperplasia in rat urinary bladder.
36 Wks.
0.05% Phenobarbital
5.0% Saccharin
0.05% Phenobarbital
/ / / 5.0% Saccharin
0.05% Phenobarbital
5.0% Saccharin
0.02% 2-AAF in diet
0.01% BBN in drinking water
Basal diet
FIGURE 5. Experimental protocol for testing organ specific-
ity of promoters in two-stage carcinogenesis in rat liver or
urinary bladder.
Table 4. Lesions of the urinary bladder in male rats initiated by different doses ofN-butyl-N(44-hydroxybutyl)nitrosamine
(BBN) followed by 5% saccharin for 32 weeks.
PN hyperplasiaa Carcinomaa
Dose of Treatment
BBN, with No. of No./10 cm of No./10 cm of
% saccharin rats Incidence, % basement membrane Incidence, % basement membrane
0.05 + 25 25 (100)* 26.2 + 18.1* 20 (80.0)* 1.3 ± 1.2*
0.05 - 26 12 (46.2) 0.7 ± 0.9 1 ( 3.8) 0.0 ± 0.1
0.01 + 29 24 (82.8)** 2.6± 2.2** 0 - 0
0.01 - 28 11 (39.3) 0.7± 1.0 0 - 0
0 + 28 0 - 0 0 - 0
aValues are means ± SD.
*p < 0.001 compared with 0.05% BBN alone.
**p < 0.001 compared with 0.01% BBN alone.
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hanced hepatocarcinogenesis and induced hepato-
cellular carcinoma after 2-AAF treatment, and it
significantly increased formation of hyperplastic
(neoplastic) liver nodules after BBN treatment
(Table 5). Saccharin significantly enhanced the in-
duction of PN hyperplasias of the urinary bladder
after BBN or 2- AAF treatment (Table 6). However,
after 2-AAF or BBN treatment, there was no effect
of phenobarbital on the urinary bladder or of sac-
charin on liver neoplasia induction. These data indi-
cate that although 2-AAF and BBN have tumor-ini-
tiating effects in both liver and urinary bladder, the
tumor- promoting effects of phenobarbital and sac-
charin are organ specific. The results are consistent
with the findings that phenobarbital did not en-
hance 7,12-dimethylbenz(a)anthracene-induced skin
tumors (16) or dimethylnitrosamine-induced lung tu-
mors and that phenobarbital increased the inci-
dence of spontaneous liver tumors, but had no effect
on the incidence of other spontaneous tumors (17).
Saccharin also did not enhance induction of fore-
stomach tumors by benzo(a)pyrene (18). Therefore,
the tumor-promoting effects of phenobarbital and
saccharin may be restricted to the liver and urinary
bladder, respectively.
Strain Differences in Susceptibility
of the Urinary Bladder to Saccharin
There are many reported differences in chemical
carcinogenesis between strains of animals (7,19).
Strain difference is one of the factors that modify
chemical carcinogenesis. Strain differences appear
to modify promotion as well as initiation in two-
stage carcinogenesis. Therefore, we tested whether
there was any strain difference in the effect of sac-
charin as a promoter.
Male 6-week-old ACI, Wistar, F344 and Sprague
Dawley (SD) rats were given diet with 5% saccha-
rin for 52 weeks or basal diet for 52 weeks as a con-
Table 5. Lesions of the liver in male rats initiated by 2-acetylaminofluorene (2-AAF) orN-butyl-N(4-hydroxybutyl)nitrosamine
(BBN) followed by phenobarbital (PB) or saccharin (S).
Hyperplastic nodule Hepatocellular carcinoma
Treatmenta No. of rats Incidence, % No./cm2b Area, mm2/cm2b Incidence, % No./cm2b Area, mm2/cm2b
2-AAF---PB 24 24 (100) 5.5+ 3.2* 3.5 + 2.1* 5(20.8)* 0.0 + 0.1** 1.3 ± 3.0*
2-AAF--S 29 27 (93.1) 3.0± 3.6 1.9± 2.4 0 - 0 0
2-AAF 28 27 (96.4) 3.6± 2.6 1.9± 1.8 0 - 0 0
BBN bPB 30 8 (26.6)* <0.1 <0.1 0 - 0 0
BBN-S 29 0 - 0 0 0 - 0 0
BBN 28 0 - 0 0 0 - 0 0
PB 29 0 - 0 0 0 - 0 0
S 28 0 - 0 0 0 - 0 0
29 0 - 0 0 0 - 0 0
aThe rats were initiated with either 0.02% 2-AAF in their diet or 0.01% BBN in their drinking water for 4 weeks followed by
either 0.05% phenobarbital or 5.0% saccharin in their diet for 32 weeks.
bValues are means ± SD.
*p < 0.05 compared with 2-AAF alone.
**p < 0.01 compared with BBN alone.
Table 6. Lesions of the urinary bladder in male rats initiated with 2-acetylaminofluorene (2-AAF) or
N-butyl-N-4-hydroxybutyl)nitrosamine (BBN) followed by phenobarbital (PB) or saccharin (S).
PN hyperplasia Papilloma
No. of No./10 cm of No./10 cm of
Treatmenta rats Incidence, % basement membraneb Incidence, % basement membraneb
2-AAF---PB 24 0 - 0 0 - 0
2-AAF---S 29 4 (13.8)* 0.3± 1.1 0 - 0
2-AAF 28 0 - 0 0 - 0
BBN--PB 30 14 (46.7) 0.6 + 0.7 9 (30.0) 0.4 + 0.8
BBN--S 29 24 (82.8)* 2.6 + 2.2 6 (20.7) 0.2 + 0.4
BBN 28 11 (39.3) 0.7 + 1.0 8 (28.6) 0.4 + 0.7
PB 29 0 - 0 0 - 0
S 28 0 - 0 0 - 0
29 0 - 0 0 - 0
aThe rats were initiated with either 0.02% 2-AAF in their diet or 0.01% BBN in their drinking water for 4 weeks followed by
either 0.05% phenobarbital or 5.0% saccharin in their diet for 32 weeks.
bValues are means ± SD.
*p < 0.05 compared with 2-AAF alone.
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trol, and then their urinary bladder was examined
by light and scanning electron microscopy.
Histological examination showed that saccharin
induced urinary bladder lesions in ACI rats, but no
changes in Wistar, F344 or SD rats (Table 7). PN hy-
perplasia and papilloma were increased significantly
in the urinary bladder of ACI rats given saccharin.
Scanning electron microscopy showed mucosal foci
with slightly elevated cells, giving a cobblestone ap-
pearance, on the luminal surface of the urinary blad-
der. The superficial epithelial cells were covered
with short, uniform microvilli and with ropy or leafy
microridges. In addition, several superficial epithe-
lial cells with pleomorphic microvilli on their lumi-
nal surface were found in these foci, as described
previously (20). These scanning electron microscopic
findings were greatest in ACI rats among the
groups given saccharin. Slight formation of pleomor-
phic microvilli and short, uniform microvilli were
seen in Wistar and F344 rats treated with saccha-
rin, but were not seen in SD rats. Thus, there was a
clear strain difference in rats in susceptibility of the
urinary bladder to saccharin. It is explained that
the promoting effect of saccharin in the urinary
bladder was greatest in ACI rats after initiation
with naturally occurring compounds. Strain differ-
ences may be one of the important factors in ex-
plaining differences of exertion of promoting effects.
Membrane Potentials of Urinary
Bladder Epithelium in Rats Treated
with Saccharin
Scanning electron microscopic studies have
shown morphological alterations, such as pleomor-
phic microvilli and short, uniform microvilli on the
bladder surface of rats treated with BBN (21),
FANFT (22), or saccharin in the early stage of the
urinary bladder carcinogenesis (20) Kakizoe et al.
(3) reported that Concanavalin A agglutinated iso-
lated bladder cells of rats treated with BBN or sac-
charin. These findings suggest that urinary bladder
carcinogens or promoters might induce changes in
physiological function of the surface membrane of
the epithelium.
We investigated the electrophysiological changes
in the membrane potential of superficial epithelial
cells of the urinary bladder in rats exposed to BBN
or saccharin. Male 6-week-old F344 rats were given
0.05% BBN in their drinking water or 5% sodium
saccharin in their diet for 8 weeks. Untreated rats
were used as controls. After 1, 2, 4 or 8 weeks on
test, groups of five rats were killed, their urinary
bladders removed, everted, and placed on a flat
plastic sheet, they were then placed in a chamber
filled with modified Krebs solution (350C) into which
95%0 2 and 5% CO2 was bubbled. Membrane poten-
tials of superficial epithelial cells of the bladder
were measured with a microelectrode filled with 3M
KCI, and with an impedance of approximately 20
megohms.
The results are summarized in Table 8. Increases
in the membrane potential of superficial epithelial
cells of the urinary bladder in rats treated with
BBN was observed from as early as week 1 to the
end of the 8 weeks experiment (p<0.001). Saccharin
administration also increased membrane potential,
the increase being significant in weeks 2 and 4 (p<
0.05). However, the membrane potentials induced
by saccharin were consistently lower than those in-
duced by BBN. In general, change in membrane po-
tential occur due to a change in K+ permeability
and/or change of Na- electrogenic pump activity so
that the increase of membrane potential in groups
treated with BBN and saccharin might reflect these
changes. Differences between the membrane poten-
tials of groups treated with BBN and saccharin,
therefore, may be related to differences in mem-
brane components.
Table 7. Histological and scanning electron microscopic changes of the urinary bladder in four strains of male rats
receiving diets containing 5% saccharin for 52 weeks.
Treatment Histology Scanningelectron microscopy
with No. of PN hyperplasia, Papilloma, Carcinoma, Pleomorphic Short, uniform
Strain saccharin rats % % % microvilli microvilli
ACI + 32 20 (62.5)* 9 (28.1)** 3 (9.4) + + + + + +
- 28 0 - 0 - 0- -
Wistar + 26 0 - 0 - 0 - + +
- 24 0 - 0 - 0- -
F344 + 25 0 - 0 - 0 - + +
- 25 0 - 0 - 0- -
Sprague-Dawley + 26 0 - 0 - 0 -
- 26 0 - 0 - 0- -
**p < 0.01 compared with no saccharin.
*p < 0.001 compared with no saccharin.68 ITO ETAL.
Table 8. Membrane potentials of the epithelium of F344 male rat urinary bladder treated with 0.05%
N-butyl-N(4-hydroxybutyl)nitrosamine (BBN) or 5% saccharin.
Membrane potential, -mVa
At 1 At2 At4 At8
Chemical week weeks weeks weeks
BBN 35.3 ± 3.3* 35.8 ± 1.5* 38.0 ± 1.9* 39.0 ± 3.5*
Saccharin 28.9 ± 1.9 31.7 ± 3.1** 31.0 ± 2.5** 33.3 ± 1.6
Control 25.6 ± 2.9 25.3 ± 2.1 25.5 ± 1.3 30.4 ± 2.0
aValues are means + SD of groups consisting of five rats each.
**p < 0.05 compared with control.
*p < 0.001 compared with control.
Conclusions
The two-stage process, initiation and promotion,
applies to urinary bladder carcinogenesis. The pro-
moting effects of 16 test chemicals on urinary blad-
der carcinogenesis in rats initiated by BBN were ex-
amined, and the in vivo biological characteristics of
the promoter saccharin were examined.
The results showed that various environmental
chemicals may have promoting effects on urinary
bladder carcinogenesis in rats. The promoting effect
of saccharin was dose-dependent and the effects of
tumor promoters were organ specific. Moreover,
there were strain differences in susceptibility to
saccharin.
These findings show that urinary bladder carcino-
genesis proceeds by a two-stage process. The con-
cept of promotion is important in assessing the car-
cinogenic risk to humans of environmental factors.
To counteract this risk we must detect not only en-
vironmental carcinogens but also environmental
promoters. Some short-term in vitro tests are rec-
ommended for definite evidence of genotoxicity.
However, promoters which are epigenetic cannot be
detected by short-term in vitro test. Therefore, an
in vivo bioassay using a marker of a preneoplastic
lesion, as in the present studies, is useful for detec-
tion of promoters of urinary bladder carcinogenesis.
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